ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Appropriations Hearings Scheduled; Zubro Heads AACI, Nelson Elected ACCC President

February 10, 1978

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

November 28, 2008

Committee Unblinds Phase III Zytiga Study

March 30, 2012

A Transcript: what Fisher Knew, When Did He Know

June 24, 1994

Guest Commentary: Donald Berry Finds Fundamental Flaws In Data Pooling Plan.

November 16, 2007

NCAB Gives Final Approval to New Guidelines for P01s

May 29, 1987